Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs  by Minden, Audrey et al.
Cell, Vol. 81, 1147-1157, June 30, 1995, Copyright © 1995 by Cell Press 
Selective Activation of the JNK Signaling Cascade 
and c-Jun Transcriptional Activity 
by the Small GTPases Rac and Cdc42Hs 
Audrey Minden,* Anning Lin,* Fran(;ois-Xavier Claret,* 
Arie Abo,t and Michael Karin* 
*Department of Pharmacology 
Program in Biomedical Science 
University of California, San Diego 
School of Medicine 
La Jolla, California 92093-0636 
tOnyx Pharmaceuticals 
3031 Research Drive 
Richmond, California 94806 
Summary 
The Rho subfamily of GTPases is involved in control 
of cell morphology in mammals and yeast. The mam- 
malian Rac and Cdc42 proteins control formation of 
lamellipodia and filopodia, respectively. These pro- 
teins also activate MAP kinase (MAPK) cascades that 
regulate gene expression. Constitutively activated 
forms of Rac and Cdc42Hs are efficient activators of 
a cascade leading to JNK and p38/Mpk2 activation. 
RhoA did not exhibit this activity, and none of the pro- 
teins activated the ERK subgroup of MAPKs. JNK, but 
not ERK, activation was also observed in response to 
Dbr, an oncoprotein that acts as a nucleotide exchange 
factor for Cdc42Hs. Results with dominant interfering 
alleles place Racl as an intermediate between Ha-Ras 
and MEKK in the signaling cascade leading from 
growth factor receptors and v-Src to JNK activation. 
JNK and p38 activation are likely to contribute to the 
biological effects of Rac, Cdc42Hs, and Dbl on cell 
growth and proliferation. 
Introduction 
Members of the Ras superfamily of small GTP-binding 
proteins have important regulatory roles in diverse cellu- 
lar functions, including mitogenesis, cytoskeletal re- 
arrangements, transcytosis, and motility (reviewed by Bo- 
koch and Der, 1993; Bourne et al., 1990; Downward, 1990; 
Hall, 1993). Whereas the Rab and Arf subfamilies control 
vesicular protein trafficking (reviewed by Ferro-Novick and 
Jehn, 1994; Rothman, 1994), the Ras and Rho subfamilies 
function in signal transduction. The Ras proteins link 
growth factor receptor activation to gene regulation 
through mitogen-activated protein kinase (MAPK) cas- 
cades that eventually lead to phosphorylation of specific 
transcription factors (reviewed by Marshall, 1995). Growth 
factor receptor activation results in recruitment of the nu- 
cleotide exchange factor Sos to the plasma membrane, 
where it activates Ras by catalyzing the exchange of GDP 
by GTP (Aronheim et al., 1994; Buday and Downward, 
1993), The Ras-GTP form recruits the serine/threonine 
kinase Raf to the plasma membrane, thereby permitting 
its activation by signals yet to be identified (Leevers et al., 
1994; Stokoe et al., 1994). Once activated, Raf phosphor- 
ylates and activates the dual specificity kinases MEK1 and 
MEK2, whose substrates are the extracellular signal- 
regulated ERK1 and ERK2 MAPKs (reviewed by Cobb and 
Goldsmith, 1995; Marshall, 1995). The activated ERKs 
phosphorylate several important cytoplasmic substrates 
and also translocate to the nucleus, where they phosphor- 
ylate transcription factors leading to immediate-early gene 
induction (reviewed by Marshall, 1995; Hill and Treisman, 
1995). The use of constitutively activated and catalytically 
inactive MEK1 mutants has offered the view that activation 
of the ERK cascade is both necessary and sufficient for 
oncogenic transformation and presumably for a mitogenic 
response (Cowley et al., 1994; Mansour et al., 1994). In- 
deed, an effector domain mutant of oncogenic Ha- 
Ras(V12) that cannot bind Raf-1 and activate the ERK 
cascade, Ha-Ras(V12;E37G), is nontransforming (White 
et al., 1995). However, another effector domain mutant, 
Ha-Ras(V12;T35S), which is fully capable of binding Raf 
and stimulating ERK activity, is compromised in its trans- 
forming activity, suggesting that additional Ha-Ras ef- 
fectors contribute to cell transformation and presumably 
mitogenesis (White et al., 1995). The identity of these ef- 
fectors is not clear. 
Recently, downstream mediators linking Ras activation 
to nuclear events were identified. Ras activation was 
shown to play a critical role in activation of members of the 
MAPK group, the c-Jun N-terminal kinases (JNKs) (also 
known as stress-activated protein kinases [SAPKs]; D6ri- 
jard et al., 1994; Kyriakis et al., 1994), in response to 
growth factors (Minden et al., 1994). Like the ERKs, the 
activated JNKs translocate to the nucleus (F. Dolfi and 
M. K., unpublished data), where they phosphorylate tran- 
scription factors such as c-Jun (Hibi et al., 1993; Suet al., 
1994) and ATF2 (Gupta et al., 1995). Although Ha-Ras 
function is essential for JNK activation by growth factors 
(but not by cytokines, such as tumor necrosis factor a 
[TNF~]), oncogenically activated Ha-Ras leads only to par- 
tial JNK activation (Minden et al., 1994). By contrast, Ha- 
Ras is sufficient for full ERK activation (de Vries-Smits et 
al., 1992; Robbins et al., 1992; Thomas et al., 1992; Wood 
et al., 1992). Another difference between the JNK and 
ERK cascades is that Raf is not directly involved in JNK 
activation (Minden et al., 1994). Instead, the JNK cascade 
is strongly activated by the MAPKKK MEKK1, which, un- 
less overexpressed, does not lead to ERK activation (Min- 
den et al., 1994; Yah et al., 1994). Although MEKK1 activity 
is stimulated by growth factors in a Ras-dependent man- 
ner (Lange-Carter et al., 1993; Lange-Carter and Johnson, 
1994), the mechanism of its activation is not clear. In yeast, 
activation of an MEKK1 homolog, STE11, by the phero- 
mone receptor appears to involve activation of another 
protein kinase, STE20 (reviewed by Herskowitz, 1995). 
Members of the Rho subfamily, although less exten- 
sively studied than the Ras subfamily, also play critical 
roles in growth factor signaling through regulation of the 
actin cytoskeleton (reviewed by Ridley, 1994). Rac regu- 
lates membrane ruffles (lamellipodia) throughformation 
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Figure 1. Activation of JNK and p38 but Not ERK by Activated Rac 
and Cdc42Hs 
(A) HeLa cells were transfected with 1 p.g of either pSRa-HA-JNK1 or 
pSRa-HA-ERK2 together with 1 ~g of either empty pSRa expression 
vector (lane C) or the indicated small GTPase expression vectors. JNK 
and ERK activities were measured by immunocomplex kinase assays 
using GST-c-Jun (G-c J) or MBP as substrates, respectively. A sample 
of each lysate was analyzed for expression of HA-JNK or HA-ERK 
by Western blot analysis using anti-HA antibody. The segments of 
the autoradiograms and fluorograms that contain the phosphorylated 
substrates and the expressed kinases are shown. The fold stimulation 
of kinase activity as quantitated with a phosphorimager is indicated 
below each lane. 
(B) NIH 3T3 cells were transfected as described in (A) using 0.5 ~g 
of each of the indicated small GTPase expression vectors or 0.2 p.g 
of Cdc42Hs(V12) expression vector. Total DNA concentration was kept 
constant using pSRa. Kinase activities were determined as described 
above. These experiments were repeated at least three times with 
similar results. 
(C) HeLa cell lysates from (A) were analyzed by immunoblotting for 
expression of Myc-tagged Racl(V12), RhoA(Vt 4), and Cdc42Hs(V12). 
" (D) HeLa cells were transfected with 1 I~g of pSRa-HA-JNK1 to- 
gether with either empty expression vector (lane C), Rac1(V12), or 
Cdc42Hs(V12) expression vectors. Cells transfected withHA-JNK1 
and empty vector were treated with or without EGF (15 ng/ml) for 15 min. JNK activity was measured as described in (A). The fold stimulation 
over unstimulated cells, as quantitated by phosphorimager, is presented. These experiments were repeated three times with similar results. 
(E) RatlA cells stably expressing Racl(V12) or Cdc42Hs(V12) and parental cells (Con) were assayed for endogenous JNK or ERK activity by 
immunocomplex kinase assays with GST-c-Jun (G-cJ) or MBP, respectively, as substrates. Parental cells were treated ~th or without EGF (15 
ng/ml for 10 rain). JNK1 expression level was measured by immunoblotting. These experiments were r peated twice with similar results. 
(F) HeLa cells were transfected with pCMV5-M2-p38 (1 p.g) together with empty expression vector (Con) or the indicated expression vectors, p38 
activity was determined by immunocomplex kinase assay using GST-ATF2A as substrate. A sample of each immunoprecipitate was analyzed 
for its content of M2-p38 by immunoblotting. This experiment was repeated twice with similar results. 
of cortical actin fibers (Ridley et al., 1992), whereas Rho 
controls formation of stress fibers (Ridley and Hall, 1992). 
Rac is also involved in activation of the NADPH oxidase 
complex in neutrophils (reviewed by Segal and Abo, 1993). 
Recently, another member of this subfamily, human 
Cdc42 (Cdc42Hs), was found to be involved in fi lopodia 
formation (Kozma et al., 1995; Nobes and Hall, 1995). Like 
the Ras proteins, the Rho-like proteins are believed to be 
activated in response to growth factors and polypeptide 
hormones (Hall, 1993; Nobes and Hall, 1994; Ridley, 
1994). With the exception of NADPH oxidase activation, 
the Rho-like proteins were hitherto thought to function ex- 
clusively in the regulation of cell morphology, an evolution- 
ary conserved role that is also displayed by Saccharo- 
myces cerevisiae Cdc42 (Cdc42Sc), which regulates bud 
site selection and cell polarity (Adams et al., 1990). Both 
Racl  and Cdc42Hs in their GTP-Ioaded states can bind 
to the p21-activated serine/threonine kinase PAK65 and 
stimulate its autophosphorylat ion activity (Manser et al., 
1994; Martin et al., 1995). Although PAK65 is a STE20 
homolog, its substrates or biological functions remain un- 
known. Recently, Racl  was found to be an important medi- 
ator of oncogenic transformation by Ha-Ras and capable 
of cooperating with a membrane-targeted form of Raf (Raf- 
CAAX; Qiu et al., 1995). Here we describe a role for Rac 
and Cdc42Hs in signal transduction to the nucleus. Consti- 
tutively activated Rac l /Rac2 and Cdc42Hs, but not RhoA, 
are efficient and specific activators of the JNK cascade, 
leading to increased c-Jun transcriptional activity. These 
proteins are also efficient activators of another MAPK, p38/ 
Mpk2 (Han et al., 1994; Lee et al., 1994; Rouse et al., 
1994), but they do not stimulate ERK activity. A dominant 
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negative Racl mutant, Racl(N 17), attenuated JNK activa- 
tion by growth factors, v-Src, and Ha-Ras. We propose 
that Racl and (possibly) Cdc42Hs are important interme- 
diates to the J NK and p38 activation cascades and serve to 
coordinate inputs from growth factor receptors and other 
extracellular stimuli. 
Results 
Activation of JNK and p38 but Not ERK by 
Activated Rac Proteins 
To examine whether other members of the Ras super- 
family, in addition to Ha-Ras, can stimulate mammalian 
MAPK cascades, we used expression vectors encoding 
constitutively activated versions of Racl, Rac2, RhoA, and 
Cdc42Hs. These GTPases were activated either by substi- 
tution of G12 or its equivalent (G14 in RhoA) by a valine 
residue (Ridley et al., 1992; Ridley and Hall, 1992; Kozma 
et al., 1995) or Q61 by a leucine residue (Xu et al., 1994). 
To test the effects on JNK and ERK activity, we cotrans- 
fected the different GTPase expression vectors with plas- 
mids encoding hemagglutinin (HA) epitope-tagged ver- 
sions of JNK1 and ERK2 (Minden et al., 1994). After 48 
hr, the transiently expressed HA-JNK1 and HA-ERK were 
isolated by immunoprecipitation, their activities were de- 
termined by phosphorylation of either gluthionine S-trans- 
ferase (GST)-c-Jun(1-79) or myelin basic protein (MBP), 
respectively, and their expression levels were determined 
by immunoblotting. Racl, Rac2, and Cdc42Hs were effi- 
cient JNK1 activators in both HeLa (Figure 1A) and NIH 
3T3 (Figure 1 B) cells. In both cell types, Rac and Cdc42Hs 
were more effective JNK activators than Ha-Ras(L61). In 
contrast, RhoA(V14) did not stimulate JNK activity, despite 
its efficient expression (Figure 1C). None of the Rho-'like 
proteins had a considerable effect on ERK2 activity, which 
was strongly stimulated by Ha-Ras(L61) (Figures 1A and 
1B). Racl(N17), which, like H a-Ras(N 17), is inactive owing 
to its higher affinity toward GDP (Feig and Cooper, 1988; 
Ridley et al., 1992), did not activate JNK and, in fact, re- 
duced its basal activity. The stimulation of JNK activity by 
either Racl(V12) or Cdc42Hs(V12) was as efficient as its 
stimulation by either epidermal growth factor (EGF) (Fig- 
ure 1D) or TNFa (data not shown; see, however, Figure 
4) treatment of the same cells. Titration experiments indi- 
cated that near-maximal JNK activation was observed with 
either 50 or 200 ng of the Cdc42Hs(V12) or Rac1(V12) 
expression vectors, respectively. At these levels, their ex- 
pression did not exceed the endogenous level of their wild- 
type counterparts by more than 6-fold (Cdc42Hs) or 1.5- 
fold (Racl). 
We measured JNK activity (both JNK1 and JNK2) in 
RatlA cells stably expressing Racl (V12) or Cdc42Hs(V12). 
In both cases, it was elevated in comparison with the un- 
stimulated parental cells (Figure 1E). The extent of JNK 
activation was similar to its response to EGF, which, owing 
to a higher basal JNK activity in these cells, was lower 
than the usual 10- to 20-fold seen in other cell lines. Even in 
these stable transformants, Racl (V12) and Cdc42Hs(V12) 
did not stimulate ERK activity. Immunoblot analysis indi- 
cated that the levels of Rac1(V12) and Cdc42Hs(V12) ex- 
pression in these stably transfected clones were no more 
than 2- to 3-fold higher than the levels of their endogenous 
wild-type counterparts (data not shown). As shown below, 
Rac and Cdc42Hs also stimulate JNK activity in COS-1 
cells (see Figure 7). 
Recently, a member of the MEK subfamily, SEKI/ 
MKK4/JNKK, was identified as an activator of both the 
JNKs and p38/Mpk2 (D~rijard et al., 1995; Lin et al., 1995). 
Another member of the MEK group, MKK3, is a specific 
p38 activator (Ddrijard et ai., 1995). To examine the effect 
of Rac1(V12) and Rac2(L61) on p38 activity, we cotrans- 
fected them with an M2-p38 expression vector. Immuno- 
complex kinase assays using GST-ATF2 as a substrate 
indicated that both Racl and Rac2 were potent p38 activa- 
tors, leading to more efficient activation than MKK3 (Fig- 
ure 1F). 
Functional Relationships among the 
Small G Proteins 
Ha-Ras(L61)-induced ruffling is inhibited by Rac1(N17) 
(Ridley et al., 1992). To examine whether Racl(N17) also 
exhibits a dominant negative effect on JNK activation by 
Ha-Ras, we cotransfected the HA-JNK1 and Ha-Ras(L61) 
expression vector with or without the Rac1(N17) vector. 
Expression of Racl(N17) led to almost complete inhibition 
of JNK activation by Ha-Ras(L61) (Figure 2A). No effect 
of Rac1(N17) on Ha-Ras (L61) expression was detected 
(data not shown). On the other hand, Ha-Ras(N17) in 
amounts sufficient for nearly complete inhibition of JNK 
activation by EGF (Minden et al., 1994; see below) had 
only a minor effect on JNK activation by Rac2(L61) (Figure 
2A). These results suggest that Rac acts downstream of 
Ha-Ras in the pathway leading to JNK activation. 
Next, we examined the relationships between Racl/ 
Rac2 and Cdc42Hs. We found that Rac1(N17) partially 
inhibited the activation of HA-JNK1 by the cotransfected 
Cdc42Hs(V12) expression vector (Figure 2B), but not by 
Rac1(V12) (data not shown). Cdc42Hs(N 17) partially inhib- 
ited HA-JNK1 activation by ct~transfected Rac2(L61), but 
somewhat less efficiently than Rac1(N17) inhibited the 
stimulation by Cdc42Hs(V12). HA-JNK1 activation by 
Cdc42Hs(V12) was completely inhibited by cotransfection 
of a truncation mutant of human PAK65. This mutant, 
PAKR(1-225), contains the regulatory domain that binds 
to either Racl • GTP or Cdc42Hs. GTP but lacks the cata- 
lytic domain (Martin et al., 1995; A. A., unpublished data). 
Cotransfection of a RhoA(N19) mutant had only a marginal 
effect on JNK activation by Rac2(L61) (Figure 2B). Thus, 
while RhoA is not involved in JNK activation, we were 
not able to draw clear conclusions whether Cdc42Hs acts 
upstream of Racl and Rac2, as previously suggested by 
examination of their morphological effects (Nobes and 
Hall, 1995; Kozma et al., 1995). However, the effect of 
Cdc42Hs(N17) on Racl-induced lamellipodia formation 
has not been examined. 
Although Ha-Ras activity is necessary for JNK activation 
in response to growth factors, Ha-Ras(L61) is considerably 
less effective than EGF in activating JNK (Minden et al., 
1994). We therefore examined whether Ha-Ras(L61) and 
Rac1(V12) can act additively to stimulate J N K activity. We 
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Figure 2. Relationships among Small GTP- 
ases Involved in JNK Activation 
(A) HeLa cells were transfected with 0.1 p,g 
of pSRa-HA-JNK1 and 1 p,g of pSRa-Ha- 
Ras(L61) in the absence or presence of either 
0.5 or 1 Ilg of pEXV-Rac1(N17) (left) or with 
1 pg of pSRa-Rac2(L61) in the absence or 
presence of 0.1 or 0.4 p_g of pS Ra-Ha-Ras(N 17) 
(right). Even the lower dose of Ha-Ras(N17) is 
sufficient o block completely growth factor ac- 
tivation of JNK (data not shown). JNK activity 
was measured by immunocomplex kinase 
assays, and HA-JNK expression was mea- 
sured by immunoblotting. After quantitation 
with a phosphorimager, the highest level of 
JNK activity was given an arbjtary value of 
100%, and the other activities are shown rela- 
tive to this value. G-c J, GST-c-Jun. 
(B) HeLa cells were transfected with 0.1 p,g of 
pSRa-HA-JNK1 and 1 #g of Rac2(L61) or Cdc42HS(V12) in the absence or presence of 0.5 and 1 p.g of Rac1(N17), 1 p,g of PAKR, 0.5 and 1 p,g 
of Cdc42Hs(N17), or 0.5 and 1 p,g of RhoA(N19) expression vectors, as indicated. HA-JNK1 activity was determined and calculated as described 
above. All of these experiments were repeated at least twice with similar results. 
found that cotransfection of the HA-JNK1 expression vec- 
tor with a saturating amount of a Ha-Ras(L61) plasmid and 
a suboptimal amount of a Rac1(V12) expression vector 
resulted in very efficient JNK activation that exceeded the 
sum of the two individual responses (Figure 3). Wild-type 
Racl did not potentiate the response to Ha-Ras(L61) (data 
not shown). 
Riicl Acts Downstream of Tyrosine Kinases 
We examined the effects of Rac1(N17) on JNK activation 
by either EGF or TNFa. Cotransfection with the Racl (N 17) 
plasmid partially inhibited the activation of HA-JNK1 by 
EGF, but hardly affected its response to TNFa (Figure 4). 
Nearly complete inhibition of the response to EGF was 
obtained by cotransfection of the Ha-Ras(N17) expression 
vector that, as previously observed (Minden et al., 1994), 
did not inhibit JNK activation by TNFa. 
T cell receptor (TCR) activation stimulates JNK activity 
(Su et al., 1994). Unlike the EGF receptor, the TCR has 
no intrinsic kinase activity, and instead it operates through 
activation of nonreceptor tyrosine kinases (Weiss and Litt- 
man, 1994). We therefore examined JNK activation in re- 
sponse to a typical nonreceptor tyrosine kinase, v-Src. 
Cotransfection with a v-Src expression vector resulted in 
efficient JNK activation (Figure 5A). Considerable inhibi- 
tion was obtained by cotransfection with Rac1(N17), and 
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Figure 3. Coexpression of Racl(V12) and Ha-Ras(L61) Leads to 
Strong JNK Activation 
NIH 3T3 cells were transfected with 0.1 p_g of pSRa-HA-JNK1 and 
either 1 p.g of empty vector (Con), 0.2 p.g of Rac1(V12), or 1 I~g of 
Ha-Ras(L61) expression vectors (alone or together), as indicated. HA- 
JNK1 activity was measured by immunocomplex kinase assays, and 
the level obtained by cotransfection with the empty expression vector 
was given an arbitary value of 1. HA-JNK1 expression was analyzed 
by immunoblotting and is shown at the bottom. 
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Figure 4. Dominant Negative Racl Inhibits JNK Activation by EGF 
HeLa cells were transfected with 1.0 I~g of HA--JNK1 and either empty 
expression vector or 0.5 or 1 I~g of Racl(N17) or 0.5 p.g of Ha-Ras(N17) 
expression vector. After 48 hr, cells Were treated either with EGF (15 
ng/ml) or human TNFa (10 ng/ml) for 15 rain prior to harvesting. HA- 
JNK1 activity was measured by immunocorn'plex kinase assays, and 
expression level was determined by immunoblotting. In each set of 
experiments, the kinase activities are expressed relative to those ob- 
tained in cells cotransfected with the empty vectors, which were given 
arbitrary values of 100% (EGF, 15-fold stimulation; TN Fa, 10-fold stim- 
ulation). The experiment was repeated three times with similar results. 
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Figure 5. Rac1(N17) Inhibits JNK Activation and Foci Formation by 
v-Src 
(A) NIH 3T3 cells were transfected with 0.1 I~g of pSRa-HA-JNK1 and 
2 p.g of empty expression vector or 1 I~g of v-Src expression vector 
either alone or with 0.5, 1, or 2 p_g of either Rac1(N17) or Ha-Ras(N17) 
plasmids, as indicated. HA-JNK1 activity was measured by immuno- 
complex kinase assay, and its expression was examined by immu- 
noblotting. JNK activity is expressed relative to the maximal level seen 
in v-Src-transfected cells, which represents 31-fold stimulation over 
the activity found in cells cotransfected with the empty vector. G-c J,
GST-c-Jun. 
(B) NIH 3T3 cells were transfected with 0.1 I~g of v-Src expression 
vector in the presence of 2 p.g of the indicated expression vectors and 
carrier DNA. After 14 days, the cells were stained, and the foci were 
counted. The data from three experiments were averaged and are 
presented as loci per microgram of v-Src expression vector. 
complete inhibition was achieved by cotransfection with 
Ha-Ras(N17). Interestingly, the dominant negative Racl  
and Ha-Ras mutants had similar relative effects on v-Src- 
mediated foci formation (Figure 5B). While cotransfection 
with Racl(N17) inhibited focus formation by v-Src by 89%, 
cotransfection with Ha-Ras(N 17) resulted in complete inhi- 
bition. Partial inhibition of v-Src-mediated transformation 
was also achieved by cotransfection of expression vectors 
encoding catalytically inactive forms of MEKK1 (81% inhi- 
bition) and JNK1 (36% inhibition). 
JNK Activation by the Dbl Oncogene Product 
Members of the Rho subfamily are activated by a variety 
of exchange factors that contain Dbl homology domains 
(reviewed by Ridley, 1994). It remains to be determined 
which exchange factor is specific to each of the Rho-like 
proteins in vivo. We examined the effects of the Dbl onco- 
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Figure 6. Rac1(N17) and PAKR Block JNKActivation bythe Dbl Onco- 
protein 
(A) HeLa cells were transfected with 0.1 p.g of pSR•-HA-JNK1 and 
either 2 p_g of empty vector, 1 p_g of Dbl, 1 p.g of Rac1(N17), 1 p.g of 
PAKR, or 0.5 p.g of Ras(N17) expression vectors, as indicated. JNK 
activity was measured by immunocomplex kinase assay and is ex- 
pressed relative to the maximal level seen in Dbl-transfected cells 
(100% equals 11.5-fold stimulation). G-c J, GST-c-Jun. 
(B) HeLa cells were transfected as described above, except that HA- 
ERK2 was used instead of HA-JNK1. Cells transfected with HA-ERK2 
and empty vector were treated with or without EGF (15 ng/ml for 15 
rain). ERK activity was measured by immunocomplex kinase assays 
using MBP as substrate. 
protein (Eva and Aaronson, 1985) on JNK activity. In vitro, 
Dbl acts as an exchange factor for Cdc42Hs and RhoA, 
but not Racl (Hart et al., 1991, 1994). Cotransfection with 
a Dbl expression vector resulted in efficient JNK activation 
(Figure 6A). To determine,whether the response to Dbl is 
mediated through Cdc42Hs or RhoA, we used the PAKR 
construct, since PAK65 binds Racl  and Cdc42Hs but not 
RhoA (Manser et al., 1994; Martin et al., 1995). Cotransfec- 
tion with either Rac1(N17) or PAKR inhibited JNK activa- 
tion by Dbl, but Ha-Ras(N17) had only a small effect on 
this response. Neither Racl(N17) nor PAKR inhibited Dbl 
expression, as determined by immunoblott ing (data not 
shown). In contrast with its effect on JNK, the Dbl expres- 
sion vector did not stimulate HA-ERK2 activity (Figure 6B). 
Activation of JNKK by Racl 
The activation of both JNK1 and p38 by Rac l  suggested 
that the protein kinase that can activate both of these 
MAPKs, SEK1/MKK4/JNKK, may mediate this response. 
Indeed, we found that cotransfection with the Rac1(V12) 
vector activated a GST- JNKK chimera whose activity was 
measured by a coupled kinase assay (Figure 7A). While 
the response to Racl  is weaker  than the response to 
MEKK1, it is worth noting that MEKK1 is a direct JNKK 
activator whose expression appears to be rate limiting, as 
even a small increase in its expressiQn results in consider- 
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Figure 7. JNKK and MEKK Act Downstream 
of Rac 
(A) COS-1 cells were transfected with a mam- 
malian GST-JNKK expression vector together 
with empty expression vector (lane C) or with 
the indicated expression vectors for MEKK and 
Rac1(V12). GST-JNKK was isolated from cell 
lysates by binding to gluthionine-Sepharose 
and JNKK activity was determined by a cou- 
pled kinase assay using recombinant JNK1 
and GST-c-Jun (G-c J) as substrates. This ex- 
periment was repeated twice with similar re- 
sults. 
(B) COS-1 cells were transfected with pSRa- 
HA-JNK1, pCMV5-MEKK, pSRa-Rac2(L61), 
pSRcz-JNKK(K116R), or empty exp~'ession vec- 
tors, as indicated. JNK activity and expression 
were determined as described above. The levels of JNK activity are expressed relative to those seen in cells cotransfected with MEKK. Owing 
to higher basal levels in COS-1 cells, the fold stimulation is not as high as in HeLa or NIH 3T3 cells. 
(C) HeLa cells were cotransfected with HA-JNK1 and either Rac1(V12), MEKKA(K432M), or empty expression vectors, as indicated. HA-JNK1 
activity was measured as described above and is expressed relative to the level found in Rac 1 (V12)-transfected cells. This experiment was repeated 
twice with similar results. 
able JNKK or JNK activation (Lin et al., 1995; Minden et 
al., 1994). Consistent with t ese results, we found that 
cotransfection with a vector encoding catalytically inactive 
JNKK blocked JNK activation by Rac2(L61) (Figure 7B). 
JNK activation by Rac1(V12) was also inhibited by cotrans- 
fection of a plasmid encoding catalytically inactive MEKK1 
(Figure 7C). Rac1(N17) did not inhibit JNK activation by 
MEKK1 (data not shown). 
Stimulation of c-Jun Transcriptional Activity 
by Rac and Cdc42Hs 
The efficient activation f the JNK cascade by Racl/Rac2 
and Cdc42Hs should result in stimulation of c-Jun transcrip- 
tional activity. Indeed, both Rac2(L61) and Cdc42Hs(V12) 
stimulated the transcriptional activity of a GAL4-c-Jun 
(1-223) fusion protein containing thec-Jun activation do- 
main (Figure 8). This stimulation is likely to depend on 
c-Jun phosphorylation because neither Rac1(V12) nor 
Cdc42Hs(V12) stimulated the activity of a GAL4-c-Jun 
(1-223;A63/73) fusion protein in which the serines that 
are phosphorylated by JNK were replaced by alanines. 
Discussion 
Members of the Rho subfamily of small GTPases, Racl, 
RhoA, and Cdc42Hs, mediate effects of growth factors 
and polypeptide hormones on the actin cytoskeleton and 
thereby affect cell morphology (Ridley and Hall, 1992; Rid- 
ley et al., 1992; Kozma et al., 1995; Nobes and Hall, 1995). 
These functions are evolutionary conserved, as the 
Cdc42Sc protein is involved in bud site selection and polar- 
ized cell growth (Adams et al., 1990). There is also circum- 
stantial evidence that the Rho-like proteins may have addi- 
tional effects on the control of cell growth and proliferation. 
For example, several members of the Dbl family, which 
may function as nucleotide exchange factors for the Rho- 
like proteins, have oncogenic activity (Adams et al., 1992; 
Hart et al., 1991, 1994; Miki et al., 1993). Furthermore, 
activated Racl cooperates with a membrane-targeted 
form of Raf (Raf-CAAX) in oncogenic transformation (Qiu 
et al., 1995). Although these effects could be mediated 
through modulation of the cytoskeleton, since oncogenic 
transformation and Ha-Ras activation in particular are as- 
sociated with cell shape changes (Bar-Sagi and Fera- 
misco, 1986; Ridley, 1994), weshow that he functions of 
Racl/Rac2 and Cdc42Hs are not limited to their effects 
on cell morphology. These proteins are efficient activators 
of a signaling cascade affecting two subgroups f MAPKs: 
the JNKs/SAPKs and p38/Mpk2. Interestingly, another 
member of this subfamily, RhoA, is incapable of activating 
this cascade, and none of the Rho-like proteins examined 
affected the ERK subgroup of MAPKs. Consistent with 
activation of the JNK cascade, both Racl and Cdc42Hs 
stimulated the transcriptional activity of c-Jun. As the'JNKs 
and probably p38 are likely to be capable of phosphorylat- 
ing other transcription factors, as well as regulatory pro- 
teins that act posttranscriptionally (Lee et al., 1994), Racl/ 
Rac2 and Cdc42Hs may mediate effects of growth factors 
and polypeptide hormones on gene expression. In that 
respect, they are similar to members of the Ras subfamily 
of GTPases, whose function in linking growth factor recep- 
tor activation to transcriptional responses via MAPK acti- 
vation is well established (Egan and Weinberg, 1993; Mar- 
shall, 1995; Hill and Treisman, 1995). 
The role of Racl/Rac2 and Cdc42Hs in JNK activation 
was established by three types of experiments. First, we 
demonstrated that constitutively activated Rac1(V12), 
Rac2(L61), and Cdc42Hs(V12) stimulate th catalytic ac- 
tivities of JNK1 and p38 by 10-to 60-fold in transient trans- 
fection assays in two different cell types, even when ex- 
pressed at relatively low levels. Stable expression of
Rac1(V12) or Cdc42Hs(V12) in a third cell type also results 
in efficient JNK activation, albeit of a lower magnitude than 
the one achieved in transient ransfection experiments. 
This difference is not su rprising, as stably transfected cells 
are likely to activate feedback pathways as part of their 
adaptation to chronic stimulation. In addition to JNK and 
p38 activation, we demonstrated that R cl activates 
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Figure 8. Rac2 and Cdc42Hs Potentiate c-Jun-Activated Transcription 
CV1 cells were transiently cotransfected with 1 p.g of a 5 x Gal4-LUC 
reporter and 10 ng of expression vectors encoding either the GAL4 
DNA-binding domain (DBD), GAL4-c-Jun(1-223), or GAL4-c-Jun(1- 
223;A63/73) fusion proteins, and 20 ng of either Rac2(L61), 
Cdc42Hs(V12), or the empty pSR~x vector. Luciferase activity was de- 
termined 16-20 hr after transfection. The results are expressed relative 
to the level of luciferase activity in cells cotransfected with GAL4-DBD 
and pSR~, which was given an arbitrary value of 1. The average of 
three experiments done in duplicate are shown. 
JNKK, a MAPKK that activates both of these MAPK types. 
These effects are specific, as ERK activity was not consid- 
erably stimulated even after transfection of rather high 
levels of Racl/Rac2 or Cdc42Hs expression vectors. Sec- 
ond, we used a dominant interfering Racl allele to block 
JNK activation by Ha-Ras, v-Src, or EGF. Based on the 
Ha-Ras(N 17) dominant negative mutant (Feig and Coolser, 
1988), Rac1(N17) is expected preferentially to bind GDP 
versus GTP and thereby have a higher relative affinity 
toward its exchange factor than its wild-type counterpart. 
The inhibitory effect of Racl(N17) is specific, as it did not 
have a considerable effect on JNK activation by either 
TNF~, which occurs through a Ras-independent mecha- 
nism (Minden et al., 1994), or by constitutively activated 
Rac1(V12), which no longer requires an exchange factor. 
In addition, it does not inhibit JNK activation by a down- 
stream component, MEKK1 (data not shown). The third 
type of experiment shows that expression of the Dbl onco- 
protein, which can act as an exchange factor for Cdc42Hs 
(Hart et al., 1991,1994), also stimulates JNK activity. This 
effect of Dbl is inhibited by Rac1(N17) but not by Ha- 
Ras(N17). JNK activation by Dbl was also blocked by ex- 
pression of the regulatory domain of PAK65, which binds 
to the GTP-Ioaded forms of Racl/Rac2 and Cdc42Hs, but 
not RhoA (Manser et al., 1994; Martin et al., 1995). As 
RhoA is not involved in JNK activation and Dbl does not 
act on Rac, these results suggest that Cdc42Hs may repre- 
sent a physiological target for Dbl. 
The use of the dominant interfering Rac1(N17) mutant 
allowed us to place Racl as a critical intermediate be- 
tween Ha-Ras and MEKK1 in the signaling pathway lead- 
ing from activated receptor and nonreceptor tyrosine 
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Figure 9. SignaITransduction through Members of the Rho Subfamily 
of Small GTPases in Budding Yeast and Mammals 
The regulation of yeast and mammalian Racl/Rac2 and Cdc42 and 
their downstream effects on cell morphology and MAPK cascades are 
summarized. Cdc42Sc is activated (through Cdc24; not shown) by 
RSR1, a Ras protein, and by BEM1, an SH3 domain protein (Bender 
and Pringle, 1989; Chenevert et al., 1992; Chang et al., 1994). Racl/ 
Rac2 and Cdc42Hs also receive input from growth factor receptors 
and possibly trimeric G protein-doupled receptors through mediators 
yet to be identified (Kozma et al., 1995; Nobes and Hall, 1995). Acti- 
vated Cdc42Sc can participate in activation of STE2O (I. Herskowitz, 
personal communication) and CLA4 (Cvr6kova et al., 1995), thereby 
affecting the pheromone response and osmotic shock MAPK cas- 
cades, respectively. Cdc42Sc induces morphological changes associ- 
ated with budding and is required for cytokinesis, possibly through 
CLA4 (Cvr~kova et al., 1995). Activated Racl/Rac2 and Cdc42Hs in- 
duce a variety of morphological changes through the actin cytoskele- 
ton (Kozma et al., 1995; Nobes and Hall, 1995; Ridley, 1994). In addi- 
tion, they probably activate PAK family members. PAK activation by 
analogy to CLA4 could mediate some of the morphological changes 
and, in addition, is speculated to activate the JNK and p38 cascades. 
kinases to JNK. Although MEKK1 activity has been sug- 
gested to be stimulated by Ha-Ras (Lange-Carter and 
Johnson, 1994), the mechanism of its activation is un- 
known. Unlike its fission yeast homolog Byr2, MEKK1 
does not interact directly with Ha-Ras (Chang et al., 1994; 
White et al., 1995). 
In trying to sort out the epistatic relationships between 
Racl/Rac2 and Cdc42Hs, we also used a dominant in- 
terfering Cdc42Hs(N 17) mutant (Kozma et al., 1995). How- 
ever, the results obtained did not allow us to draw clear 
conclusions. While Racl(N17) inhibited JNK activation by 
Cdc42Hs(V12), partial but considerable inhibition of JNK 
activation by Rac2(L61) was obtained by expression of 
Cdc42Hs(N17). In addition, this mutant may have some 
nonspecific effect, as it also partially inhibited JNK activa- 
tion by Cdc42Hs(V12) (data not shown). Thus, while it is 
plausible that Cdc42Hs acts upstream of Racl and Rac2, 
as previously suggested based orr their morphological ef- 
fects (Kozma et al., 1995; Nobes and Hall, 1995), it is worth 
noting that the effect of Cdc42Hs(N17) on Rac-induced 
lamellipodia formation was not examined. Racl/Rac2 and 
Cdc42Hs may interact with a common exchange factor, 
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thus explaining the cross inhibition. However, the exact 
identity of the relevant exchange factors and the biochemi- 
cal details of the interactions among the Rho proteins are 
not clear (Nobes and Hall, 1994). Furthermore, certain 
proteins like Bcr contain a Dbl domain and a GTPase- 
activating domain for both Rac and Cdc42Hs (Diekmann 
et al., 1991). Thus, although Cdc42Hs probably acts up- 
stream of Rac, the Cdc42Hs(N17) mutant may titrate a 
protein that is an important Rac effector. 
Although Racl acts downstream of Ha-Ras in the path- 
way leading to either lamellipodia formation (Nobes and 
Hall, 1995; Ridley et al., 1992) or JNK activation, it is not 
known how Ras activates Rac (Nobes and Hall, 1994; Rid- 
ley, 1994). Whereas Ha-Ras(N17) completely blocks JNK 
activation by EGF or v-Src, Racl(N 17) leads to only partial 
inhibition. Although the basis for these differences could 
be trivial, as Rac1(N17) is not efficiently expressed (our 
unpublished data), we note that even higher doses of 
Racl(N 17) did not completely inhibit JNK activation by the 
tyrosine kinases. A more likely explanation for these and 
previous observations, that Ha-Ras is necessary but not 
sufficient for JNK activation in response to EGF or nerve 
growth factor (Minden et al., 1994), is that receptor activa- 
tion generates another signal that synergizes with Ras to 
activate the JNK cascade. In T cells, for example, activa- 
tion of Ras either through TCR occupancy or phorbol es- 
ters results in modest JNK activation that is strongly po- 
tentiated following treatment with Ca 2+ ionophore or 
activation of the CD28 auxiliary receptor (Suet al., 1994). 
By itself, Ca 2÷ ionophore or CD28 does not stimulate JNK 
activity. Thus, the residual level of Ras activity following 
Racl(N 17) expression may be sufficient o synergize with 
the second signal to increase JNK activity. As this syner- 
gizing signal is not produced by Ha-Ras(L61), the inhibition 
of its activity by Rac1(N17) is more extensive. These re- 
sults also suggest that the relationships among tyrosine 
kinases, Ha-Ras, and Rac (and Cdc42Hs) may be more 
complex than a single sequential cascade. A somewhat 
similar situation exists in Schizosaccharomyces pombe, 
where the Ha-Ras homolog Rasl activates Scdl, a homo- 
log of Cdc24Sc, the exchange factor for Cdc42Sc (Chang 
et al., 1994). Both Cdc24 and Scdl contain a Dbl domain 
and are activated by BEM1 and Scd2, respectively (Chen- 
evert et al., 1992; Chang et al., 1994). BEM1 and Scd2 
are homologous proteins that contain SH3 domains. In 
Cdc42Sc, activity is also affected by RSRI/BUD1, a Ras- 
like protein involved in bud site selection (Bender and Prin- 
gle, 1989) that interacts with Cdc24 (1. Herskowitz, per- 
sonal communication). Thus, as illustrated in Figure 9, 
both mammalian and yeast members of the Rho subfamily 
receive input from Ras-like proteins and other sources. 
Mammalian Cdc42 was suggested to be activated by bra- 
dykinin, which operates through a trimeric G protein-cou- 
pled receptor (Kozma et al., 1995), and Rac was suggested 
to be activated by phosphatidylinositide 3-kinase in addi- 
tion to Ha-Ras (Nobes and Hall, 1995). 
This similarity extends to the downstream functions of 
the Rho-like proteins. Mutant alleles of Rasl, Scdl, and 
Scd2 affect both mating and cell morphology (Chang et 
al., 1994). While Rasl also activates both Byr2 and the 
MAPKKK that acts in the pheromone signaling cascade 
(Herskowitz, 1995), it was not clear how Scdl and Scd2 
(Cdc24 and Cdc42) affect mating. It was recently found 
that Cdc42Sc is required for activation of the pheromone 
cascade, most likely through direct binding to STE20 (1. 
Herskowitz, personal communication). Invitro, Cdc42. GTP 
stimulates STE20 autocatalytic activity (A. A., unpublished 
data). Another potential connection between Cdc42 and 
MAPK activation is provided by CLA4, a novel STE20-1ike 
kinase required for proper budding and cytokinesis in S. 
cerevisiae, but not for the pheromone-responsive MAPK 
cascade (CvrSkova et al., 1995). The Cla4 phenotype is 
rescued by growth on high salt in a manner that depends 
on activation of the osmotic stress MAPK module, which 
includes HOG1 and PBS2, suggesting a relati6nship be- 
tween them (Cvr~.kova et al., 1995). Recently, two MEKK- 
like MAPKKKs, SSK2 and SSK22, that activate PBS2 were 
identified (Maeda et al., 1995). Both JNK1 and p38 partially 
complement hog1 mutants (Galcheva-Gargova et al., 
1994; Han et al., 1994), and JNKK complements pbs2 
mutants (Lin et al., 1995). Thus, these results outline a 
remarkable volutionary conservation in regulation of the 
osmotic stress and budding pathways in yeast and JNK 
and the cell morphology pathways in mammals (Figure 9). 
Once activated, Racl, Cdc42Sc, and Cdc42Hs bind 
and presumably activate STE20-1ike kinases. In yeast, 
Cdc42Sc binds and presumably activates both CLA4 
(CvrEkova et al., 1995) and STE20 (1. Herskowitz, personal 
communication). The identity of the STE20-1ike kinase act- 
ing in the mammalian pathway is currently unknown. Al- 
though we were able to inhibit JNK activation by expressing 
the regulatory domain of PAK65, we have not succeeded 
in constructing a constitutively activated PAK65 allele to 
obtain positive evidence for its involvement in this path- 
way. In light of the results described above, the inhibitory 
effect of the PAK65 regulatory domain activation is not 
surprising, as it is expected to titrate both Ra(~l and 
Cdc42Hs and therefore it does not constitute evidence for 
the involvement of PAK65 or other family members (M. 
Cobb, personal communication) in JNK activation. How- 
ever, based on the yeast system, we proposed that a 
STE20/PAK homolog acts between Rac and MEKK. 
At this point it is not clear whether the JNK and p38 
cascades are involved in any of the morphological 
changes seen in response to Rac or Cdc42Hs activation. 
Most likely, JNK and p38 do not directly affect these 
changes because the morphological responses to Rac 
and Cdc42Hs are distinct while their effect on the MAPK 
cascades are very similar. However, it is likely that JNK 
and possibly p38 mediate some of the long-term effects 
of Racl, Cdc42Hs, and Dbl on cell growth, differentiation, 
and proliferation. The involvement of JNK in stimulation 
of AP-1 activity suggests it may be responsible for the 
increased invasiveness of Racl(V12)-expressing cells 
(Michiels et al., 1995) through induction of metalloprotein- 
ase expression. 
Experimental Procedures 
Cell Culture and Transfections 
NIH 3T3, COS-l, HeLa, and CV1 cells were cultured ~n Dulbecco's 
modified Eagle's medium (DMEM) supplemented with 10% fetal bo- 
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vine serum (FBS), 1 mM glutamate, 100 U/ml penicillin, and 100 p_g/ 
ml streptomycin. For transient ransfection assays, HeLa, COS-l, and 
NIH 33-3 cells grown in 35 mm dishes were transfected using the 
lipofectamine (GIBCO BRL) method according to the protocol of the 
manufacturer, keeping total DNA at 2 ~g per plate. Cells were har- 
vested after 48 hr. CV1 cells were transfected by calcium phosphate 
coprecipitation, keeping total DNA at 5 p.g per plate. Luciferase activity 
was assayed as described elsewhere (Lin et el., 1995). For transforma- 
tion assays, NIH 3T3 cells were cultured in DMEM supplemented with 
100/0 donor calf serum (DCS). Cells in 100 mm dishes were transfected 
with plasmid DNA together with 20 p.g of human placental DNA (a gift 
from M. Symons) by calcium phosphate coprecipitation. After 24 hr, 
cells were kept in medium containing 5°/0 DCS. The medium was 
changed every 4 days, and the number of foci was determined 10- 
14 days later. To generate stably transfected cell lines, we transfected 
Rat1 fibroblasts with pCVN expression vectors containing either 
Rac1(V12) or Cdc42Hs(V12) alleles. Prior to transfections, cells were 
trypsinized, washed, and resuspended at 1.5 x 103 cells/ml in cytomix 
buffer containing 10 mM K2HPO#'KH2PO4 (pH 7.5), 25 mM HEPES 
(pH 7.6), 2 mM EGTA, 5 mM MgCI2, 2 mM ATP, and 5 mM glutathione. 
The cell suspensions were mixed with 10 p.g of plasmid and salmon 
testis DNA and electroporated at 125 I~F, 250 V. Cells were then plated 
in 100 mm dishes, grown for 16 hr, trypsinized, resuspended in 5 ml 
of high glucose DMEM supplemented with 100/o FBS, 2 mM glutarnine, 
100 p.g/ml streptomycin, 100 U of penicillin, and plated at various 
dilutions in medium containing G418 (400 I~g/ml). G418-resistant 
clones were selected, and positive clones were identified by immuno- 
staining as described elsewhere (Martin et al., 1995). Positive clones 
were grown in 100 mm dishes to 70%-80% confluency, followed by 
serum starvation for 16 hr prior to harvesting and assaying endoge- 
nous JNK and ERK activities. 
Protein Kinase Assays 
To assay HA-JNK1 and HA-ERK2 activity, we collected cells from 35 
mm plates transfected with the various vectors in 400 ~1 of lysis buffer 
48 hr after tF~lnsfection, as described elsewhere (Minden et al., 1994). 
The kinases were immunoprecipitated with anti-HA antibody, and their 
activities were measured using 2 pg of either GST-c-Jun(1-79) or 
MBP as substrates (Minden et al., 1994; Ddrijard et al., 1994). M2-p38 
activity was similarly assayed after immunoprecipitation with the anti- 
Flag antibody (IBI/Kodak) using 2 l~g of GST-ATF2(1-254) (GST- 
ATF2A) as a substrate (D~rijard et el., 1995; Lin et al., 1995). Endoge- 
nous JNK and ERK activities were also assayed by immunocomplex 
kinase assays after immunoprecipitation of JNKI/JNK2 with anti- 
JNK(247) and anti-ERK2 TR10 antibodies as described elsewhere 
(Minden et al., 1994). TR10 was a gift from M. Weber. All experiments 
were quantitated using a phosphorimager. 
Immunoblotting 
Immunocomplexes or 25 I~g of whole-cell lysates were resolved by 
SDS-PAGE and electroblotted onto Immobilon P membranes (Milli- 
pore). After blocking, the membranes were probed with anti-HA anti- 
body or anti.JNK monoclonal antibody 333.8 (Pharmingen) as de- 
scribed elsewhere (Minden et el., 1994). Immunocomplexes were 
visualized using enhanced chemiluminescence detection (Amersham 
International). 
Plaamids 
Racl(N 17), RhoA(V14), and RhoA(N19) were expressed in the pEXV 
vector (Ridley and Hall, 1992; Ridley et al., 1992). Racl(Vf2) (Ridley 
et el., 1992) was su bcloned into pSRa (l'akabe et al., 1988) at the EcoRI 
site, Rac2(L61) (Xu et al., 1994) was subcloned into pSRa between the 
EcoRI and Hindlll sites. Cdc42Hs(V12) (Kozma et al., 1995) and Dbl 
(Hart et aL, 1991) were expressed using pCMV and pEXV expression 
vectors, respectively, pSG-v-Src was a gift from T. Deng. The HA- 
JNK1, HA-ERK2, M2-p38, MEKKt, MEKKA(K432M), human JNKK, 
human JNKK(Kt 16R), JNKI(APF), GAL4-c-Jun(f-223), and GAL4- 
c-Jun(1-223;A63/73) expression vectors were described (D6rijard et 
aL, 1994; Suet el., 1994; Minden et el., 1994; Lin et el., 1995). GST- 
ATF2(1-254) (GST-ATF2A) was constructed by inserting a BamHI- 
Ncol fragment of pRSET-His ATF2 (AbdeI-Malek Abdel Hafiz et al., 
1992) into pGEX-KG, a GST fusion protein expression vector. MKK3 
expression vector was a gift from K. Guan. PAKR contains the N-ter- 
minal Rac-binding domain of human PAK65 (amino acids 1-225) (Mar- 
tin et al., 1995) and was expressed using the pCDB vector. 
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